Evidence-based management of rapidly progressing systemic sclerosis.
about
My approach to the treatment of sclerodermaRecent Treatments of Interstitial Lung Disease with Systemic SclerosisSystemic sclerosis: commonly asked questions by rheumatologistsInterstitial lung disease: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases.Work productivity in scleroderma: analysis from the University of California, Los Angeles scleroderma quality of life study.Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exerciseThe prevalence and clinical correlates of an auscultatory gap in systemic sclerosis patientsNilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trialOld medications and new targeted therapies in systemic sclerosis.Therapeutic and diagnostic outcomes of a standardised, comprehensive care pathway for patients with systemic sclerosis.Characterisation of an epigenetically altered CD4(+) CD28(+) Kir(+) T cell subset in autoimmune rheumatic diseases by multiparameter flow cytometry.Latest advances in connective tissue disorders.Dose-escalation of human anti-interferon-α receptor monoclonal antibody MEDI-546 in subjects with systemic sclerosis: a phase 1, multicenter, open label study.Long-term efficacy and tolerability of mycophenolate mofetil therapy in diffuse scleroderma skin disease.Sustained benefit from combined plasmapheresis and allogeneic mesenchymal stem cells transplantation therapy in systemic sclerosis.Autologous hematopoietic stem cell therapy in severe systemic sclerosis: ready for clinical practice?When there's smoke there's…scleroderma: evidence that patients with scleroderma should stop smoking.Idiopathic or connective tissue disease-associated interstitial lung disease: a case of HRCT mimicry.Human adipose-derived stromal cells for cell-based therapies in the treatment of systemic sclerosis.Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease.Indications for hospitalization and in-hospital mortality in Thai systemic sclerosis.Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database.
P2860
Q24618843-5EC48CC4-8E41-45B8-9795-476B4EFDC3ADQ26773161-F7661CCA-8F2D-406B-B2D7-BA22F5BC3CE0Q27021067-23F69BE4-1960-4358-B9E5-77F393661FFFQ33956830-6F424AA7-9956-4F52-902B-1CC42D18AB05Q35700148-3F6A91FE-9CCE-4A8E-A5BF-7887DEDB248CQ35784089-590846F8-5E9A-4124-B889-F4F445291AC5Q35829760-8A48FBA1-9B64-4AF3-AB8E-78DFE9DB55D6Q35961706-50A0F492-8E9C-4BE3-884E-C60279ABEBACQ36154430-6051F919-FCC4-453C-9EAA-2F5CDE2B4EC5Q36709262-3D651521-FD30-4EC0-8D1F-CE305F73F1E5Q36773601-979A44C6-1F4F-4B78-BCE4-9C501628B41FQ37058776-0747934E-9E6E-4EE6-8F73-E2623407596BQ37690732-2EBF13F5-7D09-4767-8A4D-A34233BA07F6Q38880396-6F1E485D-CDCC-4458-BD36-6EF5E080CA87Q41066068-FB333FB0-05A0-4AAF-90F7-77AAD1AE8478Q42507582-8B84FE23-B92F-40D4-BFC8-0617098E949FQ42693931-5FEB16A6-B911-480C-931F-781CBF1FA56FQ43160934-ED77553A-40C3-4AAD-90B1-D7C400FFCC5FQ43588809-0B140620-32F4-47AF-A1A5-EF37E1F7FD09Q44282751-E72672F8-F5EC-4DDA-A61B-2E7B5AFC515AQ45007419-B150B091-9055-4292-9402-CC66356FD0DBQ46274957-A4B93648-E9BD-4AE4-A0B5-9A815B5B32E0
P2860
Evidence-based management of rapidly progressing systemic sclerosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Evidence-based management of rapidly progressing systemic sclerosis.
@en
Evidence-based management of rapidly progressing systemic sclerosis.
@nl
type
label
Evidence-based management of rapidly progressing systemic sclerosis.
@en
Evidence-based management of rapidly progressing systemic sclerosis.
@nl
prefLabel
Evidence-based management of rapidly progressing systemic sclerosis.
@en
Evidence-based management of rapidly progressing systemic sclerosis.
@nl
P2860
P1476
Evidence-based management of rapidly progressing systemic sclerosis.
@en
P2093
Christopher P Denton
Dinesh Khanna
P2860
P304
P356
10.1016/J.BERH.2009.12.002
P577
2010-06-01T00:00:00Z